Caladrius Biosciences, Inc. 4
4 · Caladrius Biosciences, Inc. · Filed May 18, 2017
Insider Transaction Report
Form 4
MYERS STEVEN S
Director
Transactions
- Award
Common Stock
2017-05-16+2,565→ 36,159 total
Holdings
- 8,434(indirect: By IRA)
Common Stock
- 1,954(indirect: By Trust)
Common Stock
- 802(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Represents an award of 2,565 Restricted Stock Units granted under the Issuer's 2015 Equity Compensation Plan that will vest on May 16, 2018. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service.
- [F2]Includes 750 shares of unvested restricted stock granted under the Issuer's 2015 Equity Compensation Plan that will vest on June 22, 2017, 1,650 shares of unvested restricted stock granted under the Issuer's 2015 Equity Compensation Plan that will vest on January 9, 2018, 2,565 shares of unvested Restricted Stock Units granted under the Issuer's 2015 Equity Compensation Plan that will vest on May 16, 2018 and 312 shares of unvested restricted stock granted under the Issuer's 2009 Equity Compensation Plan that will vest quarterly through June 2, 2018.